Dr
Nicola
Elliott

Senior Patent Attorney

London Office

Chemistry

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Nicola's patent practice is principally focussed on chemical inventions, with particular experience in the fields of pharmaceutical and veterinary medicine, agrochemicals, subsea technologies, petrochemicals, batteries and ink technologies.

Nicola has considerable experience in securing patent protection in a range of chemical technologies. As well as prosecuting patent applications in Europe and the UK, Nicola is also involved in the management of international patent portfolios covering a wide variety of jurisdictions. She has also drafted patent applications in various technical fields, and has experience in oppositions and appeals matters at the European Patent Office.

Nicola graduated from the University of Durham in the UK with a first class honours degree in chemistry in 2003. She subsequently obtained a PhD in physical chemistry from the University of Bristol also in the UK. Her PhD research involved the study of the detailed electronic structure of various small molecules, using high resolution laser spectroscopy.

Nicola joined the patent profession in 2007, qualifying as a European Patent Attorney in 2011 and a Chartered Patent Attorney in 2012. Nicola joined the London office of HGF in September 2013, having previously worked elsewhere in private practice.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MCHEM

University of Durham

PHD

University of Bristol

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Dot Inc, the accessible future and more: health tech highlights coming to CES 2023

The countdown is on for CES 2023. Taking place in Las Vegas in the first week of January each year, CES sets the global stage for innovation in the tech …

Read article

Can AI replace patent attorneys?

OpenAI recently released a dialogue-based AI chatbot called ChatGPT, which is free for anyone to try out. You can try it here (https://chat.openai.com/chat). It’s been shown that it can set, …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.